198 related articles for article (PubMed ID: 27133138)
1. The (68)Ge phantom-based FDG-PET site qualification program for clinical trials adopted by FIL (Italian Foundation on Lymphoma).
Chauvie S; Bergesio F; Fioroni F; Brambilla M; Biggi A; Versari A; Guerra L; Storto G; Musto P; Luminari S; Cabras MG; Balzarotti M; Rigacci L; Martelli M; Vitolo U; Federico M; Gallamini A
Phys Med; 2016 May; 32(5):651-6. PubMed ID: 27133138
[TBL] [Abstract][Full Text] [Related]
2. The
Bergesio F; De Maggi A; Coronado M; Pardal E; Plaza R; Hernández AC; Sarandeses MDP; Cortes M; Setoain X; Simó M; Rotger A; Grande C; Caballero MD; Chauvie S
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(3):149-154. PubMed ID: 33485832
[TBL] [Abstract][Full Text] [Related]
3. Instrumentation factors affecting variance and bias of quantifying tracer uptake with PET/CT.
Doot RK; Scheuermann JS; Christian PE; Karp JS; Kinahan PE
Med Phys; 2010 Nov; 37(11):6035-46. PubMed ID: 21158315
[TBL] [Abstract][Full Text] [Related]
4. Standardization of image quality across multiple centers by optimization of acquisition and reconstruction parameters with interim FDG-PET/CT for evaluating diffuse large B cell lymphoma.
Daisaki H; Tateishi U; Terauchi T; Tatsumi M; Suzuki K; Shimada N; Nishida H; Numata A; Kato K; Akashi K; Harada M
Ann Nucl Med; 2013 Apr; 27(3):225-32. PubMed ID: 23264065
[TBL] [Abstract][Full Text] [Related]
5. Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom.
Sunderland JJ; Christian PE
J Nucl Med; 2015 Jan; 56(1):145-52. PubMed ID: 25525180
[TBL] [Abstract][Full Text] [Related]
6. Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application--18F, 11C, 89Zr, 124I, 68Ga, and 90Y.
Soderlund AT; Chaal J; Tjio G; Totman JJ; Conti M; Townsend DW
J Nucl Med; 2015 Aug; 56(8):1285-91. PubMed ID: 26135111
[TBL] [Abstract][Full Text] [Related]
7. Technical Note: Transconvolution based equalization of positron energy effects for the use of
Prenosil GA; Hentschel M; Fürstner M; Krause T; Weitzel T; Klaeser B
Med Phys; 2017 Jul; 44(7):3761-3766. PubMed ID: 28494090
[TBL] [Abstract][Full Text] [Related]
8. Investigation of 18F-FDG 3D mode PET image quality versus acquisition time.
Brown C; Dempsey MF; Gillen G; Elliott AT
Nucl Med Commun; 2010 Mar; 31(3):254-9. PubMed ID: 20032801
[TBL] [Abstract][Full Text] [Related]
9. A Dirichlet process mixture model for automatic (18)F-FDG PET image segmentation: Validation study on phantoms and on lung and esophageal lesions.
Giri MG; Cavedon C; Mazzarotto R; Ferdeghini M
Med Phys; 2016 May; 43(5):2491. PubMed ID: 27147360
[TBL] [Abstract][Full Text] [Related]
10. Multi-site quality and variability analysis of 3D FDG PET segmentations based on phantom and clinical image data.
Beichel RR; Smith BJ; Bauer C; Ulrich EJ; Ahmadvand P; Budzevich MM; Gillies RJ; Goldgof D; Grkovski M; Hamarneh G; Huang Q; Kinahan PE; Laymon CM; Mountz JM; Muzi JP; Muzi M; Nehmeh S; Oborski MJ; Tan Y; Zhao B; Sunderland JJ; Buatti JM
Med Phys; 2017 Feb; 44(2):479-496. PubMed ID: 28205306
[TBL] [Abstract][Full Text] [Related]
11. Spatial resolution and image qualities of Zr-89 on Siemens Biograph TruePoint PET/CT.
Lee YS; Kim JS; Kim JY; Kim BI; Lim SM; Kim HJ
Cancer Biother Radiopharm; 2015 Feb; 30(1):27-32. PubMed ID: 25549151
[TBL] [Abstract][Full Text] [Related]
12. Impact of Ge-68/Ga-68-based versus CT-based attenuation correction on PET.
van Dalen JA; Visser EP; Vogel WV; Corstens FH; Oyen WJ
Med Phys; 2007 Mar; 34(3):889-97. PubMed ID: 17441234
[TBL] [Abstract][Full Text] [Related]
13. Quantifying and reducing the effect of calibration error on variability of PET/CT standardized uptake value measurements.
Lockhart CM; MacDonald LR; Alessio AM; McDougald WA; Doot RK; Kinahan PE
J Nucl Med; 2011 Feb; 52(2):218-24. PubMed ID: 21233174
[TBL] [Abstract][Full Text] [Related]
14. Qualification of National Cancer Institute-Designated Cancer Centers for Quantitative PET/CT Imaging in Clinical Trials.
Scheuermann JS; Reddin JS; Opanowski A; Kinahan PE; Siegel BA; Shankar LK; Karp JS
J Nucl Med; 2017 Jul; 58(7):1065-1071. PubMed ID: 28254874
[TBL] [Abstract][Full Text] [Related]
15. Total-body
Hu P; Zhang Y; Yu H; Chen S; Tan H; Qi C; Dong Y; Wang Y; Deng Z; Shi H
Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2384-2394. PubMed ID: 33866409
[TBL] [Abstract][Full Text] [Related]
16. Optimization of image reconstruction conditions with phantoms for brain FDG and amyloid PET imaging.
Akamatsu G; Ikari Y; Nishio T; Nishida H; Ohnishi A; Aita K; Sasaki M; Sasaki M; Senda M
Ann Nucl Med; 2016 Jan; 30(1):18-28. PubMed ID: 26337533
[TBL] [Abstract][Full Text] [Related]
17. A gate evaluation of the sources of error in quantitative
Strydhorst J; Carlier T; Dieudonné A; Conti M; Buvat I
Med Phys; 2016 Oct; 43(10):5320-5329. PubMed ID: 28105711
[TBL] [Abstract][Full Text] [Related]
18. Establishment of a UK-wide network to facilitate the acquisition of quality assured FDG-PET data for clinical trials in lymphoma.
Barrington SF; MacKewn JE; Schleyer P; Marsden PK; Mikhaeel NG; Qian W; Mouncey P; Patrick P; Popova B; Johnson P; Radford J; O'Doherty MJ
Ann Oncol; 2011 Mar; 22(3):739-745. PubMed ID: 20813876
[TBL] [Abstract][Full Text] [Related]
19. Measurement and Evaluation of Quantitative Performance of PET/CT Images before a Multicenter Clinical Trial.
Zhu Y; Geng C; Huang J; Liu J; Wu N; Xin J; Xu H; Yu L; Geng J
Sci Rep; 2018 Jun; 8(1):9035. PubMed ID: 29899470
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity and daily quality control of a mobile PET/CT scanner operating in 3-dimensional mode.
Belakhlef A; Church C; Fraser R; Lakhanpal S
J Nucl Med Technol; 2007 Dec; 35(4):229-31. PubMed ID: 18006593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
